PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes

In this podcast, Valerie Bowling, Director of PODD, walks you through what to expect at PODD 2019 in under 4 minutes. The 9th annual PODD conference features the following:

• Building a Company around a Transformative Drug Delivery Invention with MIT's Dr Robert Langer, Dr Sangeeta Bhati, Dr Giovanni Traverso and Harvard Medical School's Dr Jeffrey Karp.
• Modality Fluid Development: Tales of Evolving Pipelines and Drug Delivery Solutions with Merck's, VP, Pharmaceutical Sciences, Dr Allen Templeton
• Gene Therapy Keynote with Spark Therapeutics, President and Head of R&D, Dr Katherine High
• Zeitgeist Presentation on Immune Targeting Nanomedicine by AstraZeneca’s, VP, External Innovation and Novel Product Technologies, Dr Anand Subramony
• Conference Chair opening remarks provided by AstraZeneca's, Dr Shawn Davis

Additional Featured Speakers:

• Roche’s, Senior Portfolio Strategy Director, Dr Beate Bittner will moderate the Formulation & Device Lifecycle Management for Biotherapeutics – Clinical and Industry Perspectives on Subcutaneous Delivery panel.
• Drug Delivery Pipeline and Technologies, A Year in Review, with Pharmacircle’s, VP, Kurt Sedo
• Delivering Flexible Dosage Forms with Pfizer's Dr Advait Badkar

The 9th annual PODD conference will take place on October 7-8, 2019 in Boston, MA. Learn more at theconferenceforum.org